Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Brookline Capital Markets Sticks to Their Buy Rating for Moderna (MRNA)
https://www.tipranks.com/news/blurbs/brookline-capital-markets-sticks-to-their-buy-rating-for-moderna-mrna?utm_source=advfn.com&utm_medium=referral
Monkeypox update: FDA focuses on testing as cases continue to rise
https://healthexec.com/topics/healthcare-management/healthcare-policy/fda-issues-new-guidance-monkeypox-testing
US: Concerns Are Mounting Due to Escalating Monkeypox Outbreak
https://www.telesurenglish.net/news/US-Concerns-Are-Mounting-Due-to-Escalating-Monkeypox-Outbreak-20220908-0005.html
$SIGA alert... is manipulated!
mRNA-4157 Personalized Cancer Vaccine: The Phase 2 trial is fully enrolled and primary data are expected in 4Q 2022.
BIG NEWS OUT: MODERNA REVIEWS CLINICAL TRIAL PROGRAMS ACROSS PORTFOLIO AT 2022 R&D DAY
Interim data from Phase 1/2 propionic acidemia (PA) multi-dose Paramount trial shows mRNA-3927 was well-tolerated to date, with encouraging early signs of potential for clinical benefit
Interim data from Phase 1/2 glycogen storage disease 1a (GSD1a) single-dose Ba1ance trial shows mRNA-3745 was well tolerated to date, with encouraging early signs of potential for clinical benefit
Moderna announces a new development candidate, mRNA-3139, for ornithine transcarbamylase (OTC) deficiency, a rare genetic disorder
Phase 3 clinical trial of RSV vaccine, mRNA-1345, has enrolled more than 24,000 of the 34,000-participant target
Phase 3 immunogenicity and safety study of flu vaccine, mRNA-1010, is fully enrolled; Company to pursue accelerated approval pathway in 2023
Company is on track to report data from its Phase 2 personalized cancer vaccine (PCV) study in 4Q 2022
Personalized Cancer Vaccine
Personalized cancer vaccines (PCV) target an individual patient's unique tumor mutations to selectively treat their cancer. Moderna's PCV program is being developed in collaboration with Merck.
mRNA-4157 is a PCV candidate designed to stimulate an immune response by boosting T cells, which are believed to be necessary for a curative cancer therapy. Moderna's Phase 2 clinical trial will determine if mRNA-4157 in combination with KEYTRUDA®, an approved cancer therapy, can improve recurrence-free survival (at 12 months) in patients with resected melanoma at high risk of recurrence, compared to KEYTRUDA alone. KEYTRUDA was selected as the comparator in the trial because it is considered the standard of care for high-risk melanoma patients.
The Phase 2 trial is fully enrolled and primary data are expected in 4Q 2022.
https://investors.modernatx.com/news/news-details/2022/Moderna-Reviews-Clinical-Trial-Programs-Across-Portfolio-at-2022-RD-Day/default.aspx
this is big!!! I've been waiting for this.........
https://sports.yahoo.com/us-lawmakers-set-quiz-health-182454743.html
Thank you Oregon !!!
"We're also encouraging providers to consider treatment with the TPOXX antiviral for people infected with monkeypox when they're first diagnosed to prevent complications, lessen symptoms and potentially decrease risk for transmission, regardless of disease severity (or risk of)."
— OR Health Authority (@OHAOregon) September 7, 2022
1 days to go! We will be hosting our R&D Day at 9:00 a.m. ET on Thursday, September 8, 2022
$WINNER
Institutional Shares 29,023,148 - 39.74%
Insider Shares 28,016,560 - 38.37%
the value of being the only approved MP drug with multiple global clinical trials on deck, is much higher than where this is. There is zero reason for this share price EXCEPT manipulation. Why? Tutes not selling. What's the play? Something is up.
It's written on the wall over here- winner!!!!!!
There's an unexploded bomb in the next street.........
$SIGA
Global Monkeypox Treatment Market to Surpass US$ 258.6 Million by 2030 - Coherent Market Insights
https://www.prnewswire.co.uk/news-releases/global-monkeypox-treatment-market-to-surpass-us-258-6-million-by-2030-coherent-market-insights-802985410.html
TPOXX, a therapeutic originally approved for smallpox that is believed to be effective against monkeypox, will also be distributed under the $20 million contract.
https://www.foxnews.com/us/biden-administration-expanding-monkeypox-vaccine-distribution-20-million-amerisourcebergen-contract
Don't miss the White house update on Thursday 9/2 regards to the funding for monkeypox!
Moderna: Patient Investors Are Given Another Fantastic Buy Point On The Pullback
https://seekingalpha.com/article/4539015-moderna-another-fantastic-buy-point-on-pullback
$MRNA
New strain of monkeypox detected in the UK as officials urgently testing whether it’s a deadlier version
The strain which has just been discovered is thought to be the former more deadly version of the disease
https://www.thescottishsun.co.uk/health/9397167/new-monkeypox-detected-uk/
$SIGA
Baby hospitalized after testing positive for monkeypox
Officials said the infant in Washington State was exposed to the virus by an infected family member and is now being treated with an authorized anti-viral called TPOXX in a Seattle hospital.
https://www.avnblogfeed.com/2022/09/03/baby-hospitalized-after-testing-positive-for-monkeypox/
FDA Should Expand Access of Tecovirimat for Monkeypox Now
Unfortunately, access to tecovirimat is severely restricted due to bureaucracy.
https://www.stateofthevirus.com/blog/fda-should-expand-access-of-tecovirimat-for-monkeypox-now
stay tuned!!!!!!
$SIGA
"to read" My main reason is that I think TPOXX can help stop the spread of MPX in this country. If it shortens the duration of illness, and illness duration is similar to contagiousness duration, that alone is worth it
We need expanded TPOXX access now. We need an emergency use authorization.
https://typefully.com/grahamwalker/PtkV0yV
HHS Expanding Monkeypox Testing Capacity to Five Commercial Laboratory Companies
This week, the Department of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), began shipping orthopoxvirus tests to five commercial laboratory companies, including the nation’s largest reference laboratories, to quickly increase monkeypox testing capacity and access in every community during the ongoing monkeypox outbreak. The companies include Aegis Science, Labcorp, Mayo Clinic Laboratories, Quest Diagnostics and Sonic Healthcare
My take on the Press Briefing and all information other sources, including a Danish Study into the Bavarian Nordic Vaccine. The EU prefers TPOXX as the defence against Monkey Pox, and are going to imminently order much larger orders for all EU Countries. There are very many doubts over the Bavarian Nordic
Vaccine effectiveness
SIGA winners
https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-monkeypox
EMA -Antiviral Tecovirimat.......
TAIPEI, Sept 2 (Reuters) - Taiwan on Friday approved the use of Moderna Inc's Omicron-targeted COVID-19 vaccine as a booster shot for people aged 18 and over.
The Taiwan Food and Drug Administration said it gave approval after an overall assessment of the vaccine's effectiveness and safety as well as the "urgent domestic public health needs"
EMA Says Antiviral Tecovirimat For Monkeypox Should Be Available Shortly In EU In Larger Quantities, After A Joint Procurement Procedure
https://www.benzinga.com/general/biotech/22/09/28732512/ema-says-antiviral-tecovirimat-for-monkeypox-should-be-available-shortly-in-eu-in-larger-quantiti
$SIGA
The authors recommended new mRNA vaccines be developed before monkeypox is declared a pandemic
Paving the way for mRNA MP vaccines BIG Pharma
Read between the lines but here it is!
Those fuckers are getting in the race and before you know it
that's what you want F:D:A
A new monkeypox vaccine is needed to prevent global transmission
https://www.news-medical.net/news/20220901/A-new-monkeypox-vaccine-is-needed-to-prevent-global-transmission.aspx
I agree 100%
Canada authorized Moderna Inc's bivalent COVID-19 shots for adults on Thursday, in the country's first approval of a vaccine adapted for the highly contagious Omicron variant of the coronavirus.
EMA COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) ADOPTS POSITIVE OPINION RECOMMENDING AUTHORIZATION FOR THE USE OF MODERNA'S OMICRON-TARGETING BIVALENT BOOSTER IN THE EUROPEAN UNION
https://investors.modernatx.com/news/news-details/2022/EMA-Committee-for-Medicinal-Products-for-Human-Use-CHMP-Adopts-Positive-Opinion-Recommending-Authorization-for-the-Use-of-Modernas-Omicron-Targeting-Bivalent-Booster-in-the-European-Union/default.aspx
MODERNA RECEIVES FDA AUTHORIZATION FOR EMERGENCY USE OF OMICRON-TARGETING BIVALENT COVID-19 BOOSTER VACCINE FOR ADULTS 18 YEARS AND OLDER
https://investors.modernatx.com/news/news-details/2022/Moderna-Receives-FDA-Authorization-for-Emergency-Use-of-Omicron-Targeting-Bivalent-COVID-19-Booster-Vaccine-for-Adults-18-Years-and-Older/default.aspx
Texas reports what may be the first U.S. death from monkeypox
https://www.cnbc.com/2022/08/30/texas-reports-what-may-be-the-first-us-death-from-monkeypox.html
Australia becomes among the first countries in the world to approve the use of a next-generation bivalent COVID-19 vaccine
mRNA-1273.214, an Omicron-containing bivalent vaccine, has demonstrated significantly higher antibody titers against all tested variants, including Omicron BA.1 and BA.4/5 subvariants
Moderna expects to supply mRNA-1273.214 to Australia in September
https://finance.yahoo.com/news/therapeutic-goods-administration-provisionally-approves-050000742.html
SWISSMEDIC AUTHORIZES MODERNA’S OMICRON-TARGETING BIVALENT BOOSTER CANDIDATE, MRNA-1273.214
https://investors.modernatx.com/news/news-details/2022/Swissmedic-Authorizes-Modernas-Omicron-Targeting-Bivalent-Booster-Candidate-MRNA-1273.214/default.aspx
MODERNA TO HOST R&D DAY ON THURSDAY, SEPTEMBER 8, 2022
“Brazil receives first batch of tecovirimat to treat monkeypox”
https://olhardigital.com.br/2022/08/29/medicina-e-saude/brasil-recebe-primeiro-lote-de-tecovirimat-para-tratamento-da-variola-dos-macacos/
Baby hospitalized after testing positive for monkeypox
Officials said the infant in Washington State was exposed to the virus by an infected family member and is now being treated with an authorized anti-viral called TPOXX in a Seattle hospital.
If an INFANT is receiving TPOXX therapy in a hospital in Washington, that tells you ALL YOU NEED TO KNOW about risk/ benefit. TPOXX DESERVES IMMEDIATE EUA.
https://abcnews.go.com/WNT/video/baby-hospitalized-testing-positive-monkeypox-88948234
The Palm Springs hospital received both oral and IV forms of the medication on Aug. 22, explained Dr. Claudia Fortiche, manager of the research program at Desert Regional. The oral medication, typically three tablets taken twice a day, is the preferred treatment method, Foriche said, but an IV is available for patients who are experiencing painful mouth lesions that make it difficult to swallow. Once a patient is able to swallow, the CDC recommends that they switch to the oral form, Foriche said.
https://eu.desertsun.com/story/news/health/2022/08/26/desert-regional-medical-center-now-providing-tpoxx-medication-monkeypox-infections/7905491001/
$SIGA
A UC Davis Health study finds that the antiviral tecovirimat appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions. The study is one of the earliest studies to assess and report the outcomes of treating patients with monkeypox with this antiviral.
https://health.ucdavis.edu/coronavirus/news/headlines/uc-davis-health-study-reports-on-the-safety-efficacy-of-tecovirimat-in-treating-monkeypox/2022/08
Brazil's health agency just approved the exemption to register to import Tpoxx.
https://www.plenglish.com/news/2022/08/26/anvisa-authorizes-use-of-vaccine-and-drug-against-monkeypox-in-brazil/
RNA for Moderna’s Omicron Booster Manufactured by CIA-Linked Company
https://2ndsmartestguyintheworld.substack.com/p/rna-for-modernas-omicron-booster?r=91goq&utm_medium=ios